Statistical Methods for Assessment of Biosimilarity Using Biomarker Data

REFERENCES

• Chirino , A. J. , Mire-Sluis , A. ( 2004 ). Characterizing biological products and assessing comparability following manufacturing changes . Nature Biotechnology 22 : 1383 – 1391 .
   PubMed Web of Science ®Google Scholar
• Chow , S. C. , Hsieh , E. , Chi , E. ( 2010 ). A comparison of moment-based and probability-based for assessment of follow-on biologics . Journal of Biopharmaceutical Statistics 20 ( 1 ): 31 – 45 .
   PubMed Web of Science ®Google Scholar
• Chow , S. C. , Liu , J. P. ( 2008 ) . Design and Analysis of Bioavailability and Bioequivalence Studies. , 3rd ed. New York : Chapman and Hall/CRC Press, Taylor & Francis .
   Google Scholar
• Chow , S. C. , Shao , J. ( 2002 ) . Statistics in Drug Research. New York : Marcel Dekker .
   Google Scholar
• Chow , S. C. , Shao , J. , Li , L. ( 2004 ). Assessing bioequivalence using genomic data . Journal of Biopharmaceutical Statistics 14 : 869 – 880 .
   PubMedGoogle Scholar
• Crommelin , D. , Bermejo , T. , Bissig , M. , Damianns , J. , Kramer , I. , Rambourg , P. , Scroccaro , G. , Strukelj , B. , Tredree , R. , Ronco , C. ( 2005 ). Biosimilars, generic versions of the first generation of therapeutic proteins: Do they exist? . Contributions in Nephrology 149 : 287 – 294 .
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration . ( 2001 ) . Guidance for Industry on Statistical Approaches to Establishing Bioequivalence. Rockville , MD : Center for Drug Evaluation and Research, U.S. Food and Drug Administration .
   Google Scholar
• Food and Drug Administration . ( 2003 ) . Guidance on Bioavailability and Bioequivalence for Orally Administered Drug Products—General Consideration. Rockville , MD : U.S. Food and Drug Administration.
   Google Scholar
• Generic Pharmaceutical Association. ( 2004 ). Biopharmaceuticals (Follow-On Protein Products): Scientific Considerations for an Abbreviated Approval Pathway. Generic Pharmaceutical Association, December 8 .
   Google Scholar
• Graybill , F. , Wang , C. M. ( 1980 ). Confidence intervals on nonnegative linear combinations of variances . Journal of the American Statistical Association 75 : 869 – 873 .
   Web of Science ®Google Scholar
• Howe , W. G. ( 1974 ). Approximate confidence limits on the mean of X + Y where X and Y are two tabled independent random variables . Journal of the American Statistical Association 69 : 789 – 794 .
   Web of Science ®Google Scholar
• Hyslop , T. , Hsuan , F. , Holder , K. J. ( 2000 ). A small-sample confidence interval approach to assess individual bioequivalence . Biometrika 81 : 103 – 114 .
   Google Scholar
• Kozlowski , S. ( 2007 ). FDA Policy on follow on biologics. Presented at Biosimilars 2007, George Washington University, Washington DC .
   Google Scholar
• Liang , B. A. ( 2007 ). Regulating follow-on biologics . Harvard Journal on Legislation 44 : 363 – 373 .
   Web of Science ®Google Scholar
• Lu , Q. , Tse , S. K. , Chow , S. C. , Yang , L. Y. ( 2009 ). On assessing bioequivalence using genomic data with model misspecification . Journal of Biopharmaceutical Statistics 19 ( 4 ): 571 – 579 .
   PubMed Web of Science ®Google Scholar
• Roger , S. D. ( 2006 ). Biosimilars: How similar or dissimilar are they? . Nephrology 11 : 341 – 346 .
   PubMed Web of Science ®Google Scholar
• Roger , S. D. , Mikhail , A. ( 2007 ). Biosimilars: Opportunity or cause for concern? . Journal of Pharmaceutical Science 10 : 405 – 410 .
   Web of Science ®Google Scholar
• Schellekens , H. ( 2004 ). How similar do ‘biosimilar’ need to be? . Nature Biotechnology 22 : 1357 – 1359 .
   PubMed Web of Science ®Google Scholar
• Schall , R. , Luus , H. G. ( 1993 ). On population and individual bioequivalence . Statistics in Medicine 12 : 1109 – 1124 .
   PubMed Web of Science ®Google Scholar
• Schuirmann , D. J. ( 1987 ). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioequivalence . Journal of Pharmacokinetics and Biopharmaceutics 15 : 657 – 680 .
   PubMedGoogle Scholar
• Ting , N. , Burdick , R. K. , Graybill , F. A. , Jeyaratnam , S. , Lu , T.-F. C. ( 1990 ). Confidence intervals on linear combinations of variance components that are unrestricted in sign . Journal of Statistical Computation and Simulation 35 : 135 – 143 .
   Google Scholar
• Tse , S. K. , Chang , J. Y. , Su , W. L. , Chow , S. C. , Hsiung , C. , Lu , Q. ( 2006 ). Statistical quality control process for traditional Chinese medicine . Journal of Biopharmaceutical Statistics 16 : 861 – 874 .
   PubMed Web of Science ®Google Scholar
• Webber , K. O. ( 2007 ). Biosimilars: Are we there yet? Presented at Biosimilars 2007, George Washington University, Washington DC .
   Google Scholar